Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "continuous renal replacement therapy"

Renal replacement therapy in acute kidney injury: controversy ...

Bellomo R, Ronco C: Continuous renal replacement therapy: hemofiltration, hemodiafiltration or hemodialysis. In Critcal Care Nephrology . 2nd edition. Edited by Ronco C, Bellomo R, Kellum JA. Saunders Elsevier, Philadelphia; 2009:1354-1358. ... Critical Care, 3 weeks ago

23 images for continuous renal replacement therapy

Renal & Urology News, 1 week ago
Renal & Urology News, 2 weeks ago
Blood Purification, 1 day ago
Pharmaceutical Journal, 1 month ago
Asiaone, 1 month ago
MDLinx, 4 months ago
MDLinx, 4 months ago
MDLinx, 4 months ago
MDLinx, 4 months ago
MDLinx, 4 months ago

Intertwining extracorporeal membrane oxygenation and continuous renal replacement therapy: sense or nonsense?

We would like to comment on the excellent review by Chen and colleagues highlighting the safety and efficacy of combining extracorporeal membrane oxygenation (ECMO) and continuous renal replacement therapy (CRRT) for fluid and ...
 Critical Care1 month ago

Continuous renal replacement therapy in critically ill patients does not affect urinary neutrophil gelatinase-associated lipocalin levels

In the present study, we assessed urinary neutrophil gelatinase-associated lipocalin (uNGAL) during 24-hour continuous renal replacement therapy (CRRT) in critically ill patients. The study was performed in accordance with the ...
 Critical Care1 month ago

Iohexol Transmembrane Clearance during Modeled Continuous Renal Replacement Therapy

General Please address all your queries or problem reports to the Pay-per-View Customer Service at ppv@karger.com referring to PPV or PPV account. 1. All payments are by credit card only. The transaction is secure: standard-procedure SSL or ...
 Blood Purification1 month ago

Dialysis Modality Choice in Diabetic Patients With ESRD

Kramer A, Stel V, Zoccali C et al . An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006. Nephrol Dial Transplant 2009; 24: 35573566 Assogba FG, Couchoud C, Hannedouche T et al . Trends in the epidemiology ...
 Diabetes Care3 weeks ago
Renal & Urology News

Dialysis Modalities Show Similar Outcomes in AKI

Share this article: Research revealed no significant difference in the risk of death between continuous renal replacement therapy and extended daily dialysis. Data from randomized controlled trials show that extended daily dialysis and ...
 Renal & Urology News2 weeks ago

Method for predicting therapeutic effect of chemotherapy on renal cell cancer

The present invention developed a novel antitumor agent for renal cell carcinoma that cannot be fully treated by the existing therapies. The present invention provides an antitumor agent comprising a combination drug of tegafur/gimeracil/oteracil ...
 PharmCast1 week ago Pneumocystis jirovecii Pneumonia in Everolimus-Treated Renal Cell Carcinoma [DIAGNOSIS IN ONCOLOGY]  Journal of Clinical Oncology1 month ago

Endo Pharmaceuticals Launches the First Nasal Gel for Testosterone Replacement Therapy

The commercial launch of Natesto (testosterone nasal gel) in a metered-dose pump expands Endo's growing branded pharmaceutical men's health portfolio. DUBLIN, March 16, 2015 /PRNewswire/ --Endo Pharmaceuticals Inc., a subsidiary of Endo ...
 Pharmaceutical & Medical Packaging News1 month ago Endo Pharmaceuticals Announces the Launch of NATESTO(tm) (testosterone nasal  Finwin1 month ago Press Release: Endo Pharmaceuticals Announces the Launch of NATESTO(TM) (testosterone nasal gel), the First and Only Nasal Gel for Testosterone Replacement Therapy  iMarketReports1 month ago TRIMEL PHARMACEUTICALS : Endo Pharmaceuticals Announces the Launch of NATESTO(TM) (testosterone nasal gel), the First and Only Nasal Gel for Testosterone Replacement Therapy  4 Traders1 month ago
[x]  

Dimension Therapeutics to Develop Gene Therapy Treatments for Patients with Ornithine Transcarbamylase (OTC) Deficiency and Glycogen Storage Disease Type Ia (GSDIa)

CAMBRIDGE, Mass.--( BUSINESS WIRE )--Dimension Therapeutics, Inc. (Dimension or the Company), a rare disease company advancing novel, liver-directed treatments for diverse genetic disorders, today announced that the company is ...
 Business Wire5 days ago
[x]  

Risk factors for loss of residual renal function in children treated with chronic peritoneal dialysis

Il-Soo Ha1, Hui K Yap2, Reyner L Munarriz3, Pedro H Zambrano4, Joseph T Flynn5, Ilmay Bilge6, Maria Szczepanska7, Wai-Ming Lai8, Zenaida L Antonio9, Ashima Gulati10, Nakysa Hooman11, Koen van Hoeck12, Lina M S Higuita13, Enrico Verrina14, G√ľnter ...
 Kidney International1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less